Last month, Demis Hassabis and John Jumper of Google DeepMind were jointly awarded the 2024 Nobel Prize in Chemistry for their development of AlphaFold 3. This AI model can more accurately predict the ...

(Bloomberg) -- Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this year, according to its Nobel Prize-winning chief executive ...

In April 2025, Isomorphic Labs raised a $600 million in its first-ever external funding round, led by Thrive Capital. Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed ...

(Bloomberg) -- Discovering new medicines takes years and is marred by an astronomical failure rate. The Nobel Prize-winning head of Alphabet Inc.’s artificial intelligence lab says the technology will ...

WIRED spoke with DeepMind’s Pushmeet Kohli about the recent past—and promising future—of the Nobel Prize-winning research project that changed biology and chemistry forever. To understand what the ...

Artificial intelligence (AI) is reshaping the scientific landscape, offering fantastic solutions to some of the most pressing global challenges. From combating climate change to transforming ...

Proteins are the microscopic workhorses of the human body, driving everything from oxygen transport to muscle contraction. Their complex 3D structures dictate their function, and understanding these ...

Demis Hassabis and John Jumper are the developers behind AlphaFold, an algorithmic model that can predict the 3D shape of proteins from their amino acid sequences. The model lets researchers visualize ...

On a rare sunny day in London at the Google DeepMind office, Colin Murdoch saw the bank deposit from his employer come through. It wasn't his paycheck. Google was investing in his startup. The ...

Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed drugs, its president, Colin Murdoch, told Fortune. Born from DeepMind’s AlphaFold breakthrough, the company is pairing ...